Gezielt nachschlagen
Suche
Suche startet nach einer kurzen Eingabepause.
20 angezeigte Treffer · Seite 2, keine Gesamtzahl für „patient“
Suchtreffer
Begriffe & Kennungen
Abevmy · 4.8 · From a clinical trial in patients with persistent, recurrent, or metastatic cervical cancer (study GOG- 0240),
Eintrag öffnenAbevmy · 4.8 · From a clinical trial in patients with persistent, recurrent, or metastatic cervical cancer (study GOG- 0240),
Eintrag öffnenAbevmy · 4.8 · From a clinical trial in patients with persistent, recurrent, or metastatic cervical cancer (study GOG-0240),
Eintrag öffnenAbevmy · 4.8 · Grade 3-5 (NCI-CTCAE v.3) venous thromboembolic reactions have been reported in up to 7.8% of patients treated
Eintrag öffnenAbevmy · 4.8 · In NSABP C-08, a phase III trial of bevacizumab in adjuvant treatment of patients with colon cancer, the incid
Eintrag öffnenAbevmy · 4.8 · In a trial of patients with persistent, recurrent or metastatic cervical cancer, the incidence of GI-vaginal f
Eintrag öffnenAbevmy · 4.8 · In clinical trials, proteinuria has been reported within the range of 0.7% to 54.7% of patients receiving beva
Eintrag öffnenAbevmy · 4.8 · In most clinical trials of bevacizumab, patients with pre-existing CHF of NYHA (New York Heart Association) II
Eintrag öffnenAbevmy · 4.8 · In patients developing PRES, early recognition of symptoms with prompt treatment of specific symptoms includin
Eintrag öffnenAbevmy · 4.8 · In patients with NSCLC excluding predominant squamous histology, all Grade reactions were seen with a frequenc
Eintrag öffnenAbevmy · 4.8 · In some clinical trials anaphylactic and anaphylactoid-type reactions were reported more frequently in patient
Eintrag öffnenAbevmy · 4.8 · In study JO25567, all grade hypertension was observed in 77.3% of the patients who received bevacizumab in com
Eintrag öffnenAbevmy · 4.8 · Major or massive pulmonary haemorrhage/haemoptysis has been observed primarily in trials in patients with non-
Eintrag öffnenAbevmy · 4.8 · Most patients who developed CHF during mBC trials showed improved symptoms and/or left
Eintrag öffnenAbevmy · 4.8 · Patients who have experienced a venous thromboembolic reaction may be at higher risk for a recurrence if they
Eintrag öffnenAbevmy · 4.8 · The incidence of CNS bleeding in patients with untreated CNS metastases receiving bevacizumab has not been pro
Eintrag öffnenAbevmy · 4.8 · The most frequently observed adverse reactions across clinical trials in patients receiving bevacizumab were h
Eintrag öffnenAbevmy · 4.8 · The overall safety profile of bevacizumab is based on data from over 5,700 patients with various malignancies,
Eintrag öffnenAbevmy · 4.8 · The risk of bevacizumab-associated hypertension did not correlate with the patients’ baseline characteristics,
Eintrag öffnenAbevmy · 4.8 · There have been rare reports of bevacizumab-treated patients developing signs and symptoms that are consistent
Eintrag öffnen